Skip to main content
logo
Great Novel Therapeutics Biotech & Medicals (TPEX:7427)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
72.60
+0.70 (0.97%)
Aug 17, 2026, 1:58 PM CST

TPEX:7427 Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
3,0801,3741,4842,5621,823936
Market Cap Growth
113.71%-7.38%-42.09%40.55%94.83%-
Enterprise Value
2,6408838842,0631,731777
Last Close Price
72.3030.3932.2960.9752.0933.38

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
2555.701140.63880.65528.303376.081485.29
PB Ratio
6.122.732.344.796.594.49
P/TBV Ratio
6.472.892.455.076.987.81

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
-732.61524.33425.313205.061233.73

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.020.020.020.03--
Net Debt / Equity Ratio
-0.87-0.87-0.90-0.87-0.89-0.60
Net Debt / EBITDA Ratio
4.644.645.277.323.693.57
Net Debt / FCF Ratio
5.015.017.257.993.213.68
Asset Turnover
0.000.000.000.010.000.00
Inventory Turnover
0.460.460.15---
Quick Ratio
23.1923.1926.7729.9520.565.79
Current Ratio
24.1224.1227.4330.4720.875.80
Return on Equity (ROE)
-17.16%-17.16%-17.97%-15.04%-27.68%-21.80%
Return on Assets (ROA)
-10.46%-10.46%-11.51%-9.68%-16.58%-12.83%
Return on Capital Employed (ROCE)
-19.60%-19.60%-17.60%-12.10%-24.90%-17.50%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-3.17%-7.09%-7.07%-2.38%-3.68%-3.83%
FCF Yield
-2.85%-6.39%-5.32%-2.26%-4.23%-3.63%
Buyback Yield / Dilution
-4.46%-4.46%-13.60%-50.23%-14.54%-33.09%